Literature DB >> 20640055

Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Philip J Norris1, Dale F Hirschkorn, Deborah A DeVita, Tzong-Hae Lee, Edward L Murphy.   

Abstract

Most human T cell leukemia virus type 1 (HTLV-1) infected subjects remain asymptomatic throughout their lives, with a few individuals developing HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) or adult T cell leukemia. Lymphocytes from about half of HTLV-1 infected subjects spontaneously proliferate in vitro, and how this phenomenon relates to symptomatic disease outcome and viral burden is poorly understood. Spontaneous proliferation was measured in lymphocyte subsets, and these findings were correlated with HTLV-1 proviral load and Tax expression in PBMCs. We found that in addition to previously described vigorous CD8+ T cell spontaneous proliferation, natural killer (NK) cells spontaneously proliferated to a similar high level, resulting in expansion of CD56-expressing NK cells. Spontaneous NK cell proliferation positively correlated with HTLV-1 proviral load but not with Tax expression or the presence of HAM/TSP. The strongest correlate with clinical outcome in this cohort was the ability of cells to express Tax, while HTLV-1 proviral load was more closely related to spontaneous NK cell proliferation. These results demonstrate that spontaneous proliferation, Tax expression, and proviral load are inter-related but not equivalent, and that spontaneous lymphocyte proliferation is not restricted to T cells, the targets of HTLV-1 infection.

Entities:  

Keywords:  HAM/TSP; HTLV; NK cell; T cell; Tax

Mesh:

Substances:

Year:  2010        PMID: 20640055      PMCID: PMC2903746          DOI: 10.4161/viru.1.1.9868

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  47 in total

1.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 2.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

3.  Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.

Authors:  E L Murphy; S A Glynn; J Fridey; J W Smith; R A Sacher; C C Nass; H E Ownby; D J Wright; G J Nemo
Journal:  Arch Intern Med       Date:  1999-07-12

Review 4.  The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.

Authors:  Ken Murata; Yasuaki Yamada
Journal:  Int Rev Immunol       Date:  2007 Sep-Dec       Impact factor: 5.311

5.  Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.

Authors:  Joshua Arnold; Bevin Zimmerman; Min Li; Michael D Lairmore; Patrick L Green
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

Review 6.  Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy.

Authors:  Unsong Oh; Steven Jacobson
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

7.  Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.

Authors:  Prabal Banerjee; Gerold Feuer; Edward Barker
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

8.  In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.

Authors:  Yan Zhang; Diana L Wallace; Catherine M de Lara; Hala Ghattas; Becca Asquith; Andrew Worth; George E Griffin; Graham P Taylor; David F Tough; Peter C L Beverley; Derek C Macallan
Journal:  Immunology       Date:  2007-03-07       Impact factor: 7.397

9.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Mineki Saito; Toshio Matsuzaki; Yorifumi Satou; Jun-Ichirou Yasunaga; Kousuke Saito; Kimiyoshi Arimura; Masao Matsuoka; Yoshiro Ohara
Journal:  Retrovirology       Date:  2009-02-19       Impact factor: 4.602

10.  Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response.

Authors:  Agnieszka Kielczewska; Michal Pyzik; Tianhe Sun; Astrid Krmpotic; Melissa B Lodoen; Michael W Munks; Marina Babic; Ann B Hill; Ulrich H Koszinowski; Stipan Jonjic; Lewis L Lanier; Silvia M Vidal
Journal:  J Exp Med       Date:  2009-03-02       Impact factor: 14.307

View more
  15 in total

1.  The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease.

Authors:  Steven Jacobson
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

2.  Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.

Authors:  Elizabeth Jaworski; Aarthi Narayanan; Rachel Van Duyne; Shabana Shabbeer-Meyering; Sergey Iordanskiy; Mohammed Saifuddin; Ravi Das; Philippe V Afonso; Gavin C Sampey; Myung Chung; Anastas Popratiloff; Bindesh Shrestha; Mohit Sehgal; Pooja Jain; Akos Vertes; Renaud Mahieux; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

Review 3.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

Review 4.  Human T cell leukemia virus type 1 and Zika virus: tale of two reemerging viruses with neuropathological sequelae of public health concern.

Authors:  DeGaulle I Chigbu; Pooja Jain; Brenndan L Crumley; Dip Patel; Zafar K Khan
Journal:  J Neurovirol       Date:  2019-01-28       Impact factor: 3.739

Review 5.  HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status.

Authors:  Elisabetta Pilotti; Maria V Bianchi; Andrea De Maria; Federica Bozzano; Maria G Romanelli; Umberto Bertazzoni; Claudio Casoli
Journal:  Front Microbiol       Date:  2013-12-23       Impact factor: 5.640

6.  Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers.

Authors:  Raimundo Coutinho; Maria Fernanda Rios Grassi; Ana Beatriz Korngold; Viviana Nilla Olavarria; Bernardo Galvão-Castro; Rita Elizabeth Mascarenhas
Journal:  BMC Infect Dis       Date:  2014-08-22       Impact factor: 3.090

7.  Expansion of natural killer cells in peripheral blood in a Japanese elderly with human T-cell lymphotropic virus type 1-related skin lesions.

Authors:  Shinsaku Imashuku; Naoko Kudo; Kagekatsu Kubo; Kouichi Ohshima
Journal:  Case Rep Dermatol Med       Date:  2014-11-09

8.  Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives.

Authors:  Mineki Saito; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2012-02-06

9.  CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Authors:  Soraya Maria Menezes; Daniele Decanine; David Brassat; Ricardo Khouri; Saul V Schnitman; Ramon Kruschewsky; Giovanni López; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Anne-Mieke Vandamme; Bernardo Galvão-Castro; Roland Liblau; Johan Van Weyenbergh
Journal:  J Neuroinflammation       Date:  2014-01-29       Impact factor: 8.322

10.  The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Houshang Rafatpanah; Reza Farid Hosseini; Seyed Hassan Pourseyed
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.